XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Net Income $ 194,132 $ 179,919
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion, and amortization 103,372 96,736
Deferred income taxes 1,101 (766)
Share-based compensation 13,901 13,276
(Gain) loss on the disposal of property, plant, and equipment, and intangibles, net 178 45
Loss on sale of businesses, net [1] 5 2,476
Other items 5,460 939
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net 88,134 54,547
Inventories, net (25,266) (26,328)
Other current assets (355) 2,885
Accounts payable (27,545) (19,059)
Accruals and other, net (57,044) (44,670)
Net cash provided by operating activities 296,073 260,000
Investing activities:    
Purchases of property, plant, equipment, and intangibles, net (110,746) (98,168)
Proceeds from the sale of property, plant, equipment, and intangibles 275 206
Proceeds from Divestiture of Businesses, Net of Cash Divested 0 439
Acquisition of businesses, net of cash acquired 0 (87,935)
Payments for (Proceeds from) Other Investing Activities (2,392) 0
Net cash used in investing activities (112,863) (185,458)
Financing activities:    
Payments on long-term obligations (35,000) 0
Proceeds (Payments) under credit facilities, net (107,162) 13,240
Deferred financing fees and debt issuance costs 0 (1,206)
Acquisition related deferred or contingent consideration (42) (452)
Repurchases of ordinary shares (14,434) (37,866)
Cash dividends paid to ordinary shareholders (65,560) (60,220)
Proceeds from issuance of equity to minority shareholders 2,258 0
Net cash used in financing activities (199,319) (63,529)
Effect of exchange rate changes on cash and cash equivalents 8,556 (6,110)
Cash and cash equivalents at beginning of period 319,581 220,633
Cash and cash equivalents at end of period 312,028 225,536
Proceeds from (Payments for) Other Financing Activities 20,621 22,975
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $ (7,553) $ 4,903
[1] For more information regarding our recent acquisitions and divestitures refer to our Annual Report on Form 10-K for the year ended March 31, 2020, dated May 29, 2020.